Journal
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
Volume 52, Issue 1, Pages 92-94Publisher
DUSTRI-VERLAG DR KARL FEISTLE
DOI: 10.5414/CPXCES13EA08
Keywords
lung cancer; EGFR inhibitors; drug resistance; EMT; microRNA